Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized plus intravenous colistin for VAP in neonates
NCT02806141Phase 3Terminated
- Sponsor
- Hat Yai Hospital Medical Education Center
- Start
- Sep 2016
- Primary completion
- Oct 2017
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of colistin in ventilator-associated pneumonia (VAP), sponsored by Hat Yai Hospital Medical Education Center. Primary endpoints: Number of Patients With Cure at 2 weeks and Number of Patients With Improved at 2 weeks. Started Sep 2016; status: terminated.
02
Drugs
colistin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT02806141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806141.